3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
8
Terminated
6
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
10
Other hematologic neoplasm
2
Thoracic
1
Myeloid
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Myelodysplastic Syndromes
187
Leukemia, Myeloid, Acute
159
Myeloproliferative Disorders
83
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
72
Precursor Cell Lymphoblastic Leukemia-Lymphoma
61
Primary Myelofibrosis
54
Leukemia, Myelomonocytic, Chronic
44
Leukemia
35
Polycythemia Vera
33
Multiple Myeloma
30
Hematologic Neoplasms
30
Thrombocythemia, Essential
29
Lymphoma, Non-Hodgkin
28
Leukemia, Biphenotypic, Acute
25
Hodgkin Disease
25
Lymphoma
23
Myelodysplastic-Myeloproliferative Diseases
18
Leukemia, Lymphocytic, Chronic, B-Cell
18
Leukemia, Myeloid, Chronic-Phase
14
Blastic Plasmacytoid Dendritic Cell Neoplasm
14
Neoplasms
13
Burkitt Lymphoma
12
Mastocytosis
11
Leukemia, Myeloid
11
Graft vs Host Disease
11
Blast Crisis
11
Anemia, Refractory, with Excess of Blasts
11
Lymphoma, Follicular
10
Anemia, Aplastic
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Interventions
Tranexamic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Thrombocytopenia
×
Myeloid
×
Clear all
NCT06599762
2026-04-22
MYELO-CAN:TXA
University of Manitoba
Phase 2
Recruiting
75 enrolled